Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 27, 2015 07:20 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Presents Late-Breaking Poster at the European Society of Cardiology's Heart Failure 2015/2nd World Congress on Acute Heart Failure

HAMPTON, N.J., May 27, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive results from a recent pig study...
May 20, 2015 07:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Adds to Experienced Drug and Device Development Management Team

HAMPTON, N.J., May 20, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, LLC (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it has further strengthened its management...
May 15, 2015 16:07 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Reports 2015 First Quarter Financial and Operational Results

HAMPTON, N.J., May 15, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the first quarter ended...
May 13, 2015 07:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Appoints Two New Independent Board Members

HAMPTON, N.J., May 13, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointments of Scott P. Bruder, M.D., Ph.D....
May 07, 2015 07:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Forms Scientific Advisory Board for INOpulse(R) Programs

HAMPTON, N.J., May 7, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the formation of an INOpulse® Scientific...
May 05, 2015 08:03 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics to Present Late-Breaking Poster at the European Society of Cardiology's Heart Failure 2015/2nd World Congress on Acute Heart Failure

HAMPTON, N.J., May 5, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it will present results from a recent pig...
March 31, 2015 06:30 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Reports 2014 Full Year Financial and Operational Results

HAMPTON, N.J., March 31, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today reported financial results for the year ended December...
March 25, 2015 06:05 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Selects Flextronics to Manufacture the Mark2, Next-Generation INOpulse(R) Device

HAMPTON, N.J., March 25, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it has selected Flextronics International...
March 16, 2015 16:44 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics to Ring the NASDAQ Stock Market Closing Bell

HAMPTON, N.J., March 16, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, LLC (Nasdaq:BLPH) a clinical stage biotherapeutics company, today announced that it will preside over the ceremonial NASDAQ...
February 19, 2015 17:30 ET | Source: Bellerophon Therapeutics LLC

Bellerophon Therapeutics Announces Closing of Its Initial Public Offering

Hampton, N.J., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) announced today the closing of its initial public offering of 5,000,000 shares of common stock at a public...